CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
Original article

STAT+: 931 days. The drug approval scandal hiding in plain sight

RegulatoryNegative
AI Analysis

Summary

Northwest Biotherapeutics' brain cancer treatment has been pending regulatory approval for 931 days (approximately 2.5 years) since submission. The article suggests a drug approval scandal or concerning delay in the approval process.

Importance:6/10
Sentiment:
-0.60
regulatory approvaldrug approval delaybrain cancerFDA
Related Companies

Read the original article

Published by STAT News on July 9, 2026 10:30 AM

Read Original